Real-world data to advance HER2-targeted cancer medicines research: Playing to the strengths of clinical registry and administrative data
Asia Pac J Clin Oncol
.
2021 Aug;17(4):414-415.
doi: 10.1111/ajco.13554.
Epub 2021 Feb 19.
Authors
Monica Tang
1
,
Benjamin Daniels
1
,
Andrea L Schaffer
1
,
Sallie-Anne Pearson
1
Affiliation
1
Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia.
PMID:
33608985
DOI:
10.1111/ajco.13554
No abstract available
Keywords:
breast neoplasms; cardiotoxicity; observational study; registries; trastuzumab.
Publication types
Letter
MeSH terms
Humans
Neoplasms* / drug therapy
Receptor, ErbB-2*
Registries
Trastuzumab
Substances
Receptor, ErbB-2
Trastuzumab
Grants and funding
1151479/National Health and Medical Research Council Postgraduate Research Scholarship
DS-18-01/National Breast Cancer Foundation Postgraduate Scholarship
Translational Cancer Research Network Clinical PhD Scholarship
1158763/National Health and Medical Research Council Early Career Fellowship